Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
Phase of Trial: Phase II/III
Latest Information Update: 11 Nov 2019
Price : $35 *
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Adverse reactions
- Acronyms LIBERTY ASTHMA TRAVERSE; TRAVERSE
- Sponsors Sanofi
- 16 Oct 2019 Status changed from active, no longer recruiting to completed.
- 19 Jul 2019 This trial was completed in Germany, according to European Clinical Trials Database.
- 05 Jun 2019 This trial has been completed in Spain, according to European Clinical Trials Database.